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Abstract
Transforming growth factor-β1 (TGF-β) is involved in multiple cellular processes through Src 
activation. In the canonical pathway, Src activation is initiated by pTyr530 dephosphorylation 
followed by a conformational change allowing Tyr419 auto-phosphorylation. A non-canonical 
pathway in which oxidation of cysteine allows bypassing of pTyr530 dephosphorylation has been 
reported. Here, we examined how TGF-β activates Src in H358 cells, a small cell lung carcinoma 
cell line. TGF-β increased Src Tyr419 phosphorylation, but surprisingly, Tyr530 phosphorylation 
was increased rather than decreased. Vanadate, a protein tyrosine phosphatase inhibitor, 
stimulated Src activation itself, but rather than inhibiting Src activation by TGF-β, activation by 
vanadate was additive with TGF-β showing that pTyr530 dephosphorylation was not required. 
Thus, the involvement of the non-canonical oxidative activation was suspected. TGF-β increased 
extracellular H2O2 transiently while GSH-ester and catalase abrogated Src activation by TGF-β. 
Apocynin, a NADPH oxidase inhibitor, inhibited TGF-β-stimulated H2O2 production. 
Furthermore, mutation of cysteines to alanine, 248C/A, 277C/A, or 501C/A abrogated, while 
490C/A significantly reduced, TGF-β-mediated Src activation. Taken together, the results indicate 
that TGF-β-mediated Src activation operates largely through a redox dependent mechanism, 
resulting from enhanced H2O2 production through an NADPH oxidase and that cysteines 248, 
277, 490, and 501 are critical for this activation.
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Introduction
Src is a ubiquitously expressed non-receptor tyrosine kinase belonging to the Src family of 
protein tyrosine kinases (SFKs). By coupling signals from cell surface receptors and various 
intracellular signaling pathways (1), Src is involved in various fundamental cellular 
processes, including proliferation, differentiation, and transformation (2). Src also plays a 
critical role in epithelial-mesenchymal transition (EMT) (3-7), a process implicated in both 
wound healing and cancer metastasis (8-11).
In the canonical Src activation pathway, under basal conditions in vivo, a Src molecule 
remains inactive as a result of the intramolecular interactions between its SH3 domain and 
linker region, and its SH2 domain and the phosphorylated Tyr530 (pTyr530) in the C-
terminal negative regulatory region (12,13). Upon stimulation, pTyr530 is dephosphorylated 
thus dissociating the inhibitory intracellular interactions and allowing Src to 
autophosphorylate at Tyr419 and restoring full activity (14-17). Thus, in the canonical 
pathway phosphorylation/dephosphorylation of Tyr530 plays a critical role in Src activation/
deactivation. Several kinases and protein tyrosine phosphatases (PTPs) are involved in Src 
regulation (18), including C-terminal Src kinase (Csk) and Csk homologous kinase (Chk), 
that phosphorylate Src at Tyr530, and PTP1B, SHP1, PTPα, or PTPγ that reportedly 
catalyze Tyr530 dephosphorylation (18).
It has been well established that reactive electrophiles, such as H2O2, can participate in 
signal transduction by acting as second messengers through modification of the activity of 
signaling molecules. This so called redox signaling mechanism underlies the regulation of 
signaling pathways induced by many stimuli, including various physiological and/or 
pathological stimuli. Signaling molecules containing redox sensitive moieties such as 
cysteine, which readily reacts with electrophiles, have been found to be potential targets of 
regulation through redox mechanisms. PTPs have been recognized as major switches in 
redox signaling (19-25). PTPs all have a catalytic site structure in which a reactive cysteine 
moiety (26,27) is potentially susceptible to oxidative modification by H2O2. The oxidization 
is however, likely mediated by an enzyme, as the non-enzymatic rate of reaction with H2O2 
is too slow to account for the inactivation (28). Redox modification inhibits the activity of 
PTPs and leads to increased phosphorylation of their corresponding substrate signaling 
molecules, resulting in altered signaling pathways.
Accumulating evidence suggests that Src can also be activated through a redox dependent 
mechanism. Purified Src is activated in vitro through either oxidation or alkylation of two 
cysteine (cys) residues on the protein (29). In vivo, Src is activated by various reactive 
oxidants such as cigarette smoke (30), acrolein (30), peroxynitrite, and hydrogen peroxide 
(H2O2) (31-34). In addition, Src activation by many other stimuli including some growth 
factors seems to involve redox mechanisms (35-38).
There are nine cysteine residues in human Src that are highly conserved among Src family 
members and species (39), some of which have been implicated in Src activity regulation by 
oxidative stimuli. Senga first reported that mutation of Cys487 in v-Src (corresponding to 
Cys 490 in human Src) suppressed its activity while mutation of others changed Src stability 
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(39). In an in vitro assay, Cys277 seemed critical for the homodimerization and activation of 
Src (40). Giannoni et al. found that Cys245 and Cys487 in v-Src (corresponding to Cys248 
and Cys490 in human respectively) were involved in Src activation by oxidants, and 
dephosphorylation of Tyr530 was important for the early (10min) activation of Src, while a 
redox mechanism was involved in the late phase of Src activation (45min) in response to 
extracellular matrix (35).
Transforming growth factor-β1 (TGF-β) is a potent multifunctional growth factor involved 
in the regulation of cellular proliferation, differentiation and survival, and plays a 
predominant role in the EMT process (41). TGF-β initiates signaling through binding to its 
type II receptor, which recruits and phosphorylates type I TGF-β receptor. The type I 
receptor, a serine/threonine protein kinase, phosphorylates and activates diverse downstream 
signaling pathways, including ERK, JNK, p38MAPK, PI3K/AKT, and transcription factors 
such as SMAD2/3 (42).
Many effects of TGF-β are mediated through Src-mediated signaling pathways (43-45). 
How TGF-β activates Src is not completely clear. Some studies demonstrated that TGF-β 
could induce the production of oxidants that contributed to TGF-β-mediated effects (43,46), 
however, little is known about the role of oxidants in the activation of Src by TGF-β. Here, 
we report that a redox dependent mechanism, most likely involving cysteines of both Src 
and the PTPs that regulate its activity, is involved in Src activation by TGF-β in a non-
canonical redox activation of Src.
Materials and Methods
Chemicals and reagents
Unless otherwise noted, all chemicals were from Sigma (St. Louis, MO). Antibodies to Src 
and phosphorylated Src were from Cell Signaling Technology, Inc. (Danvers, MA). M-PER 
Mammalian Protein Extraction Reagent was from Thermal Fisher Scientific Inc. (Thermal 
Fisher, Rockford, IL). Amplex Red reagent was from Life Technologies (Grand Island, NY). 
All chemicals used were at least analytical grade.
Cell culture and treatment
A human non-small cell lung carcinoma cell line (H358) was used. H358 cells were cultured 
in RPMI-1640 medium with 10% fatal bovine serum (FBS), 100 U/ml penicillin, and 100 
μg/ml streptomycin, in a humidified incubator containing 5% CO2 at 37°C. Cells were 
treated when about 85% confluent. In catalase experiment, catalase (final concentration is 30 
U/ml) was added to the culture medium immediately before TGF-β exposure.
Western Analysis
Briefly, cell lysate was extracted with M-PER and 30 μg protein was electrophoresed on a 
4-20% Tris-glycine acrylamide gel (Invitrogen, Carlsbad, CA) and transferred to 
polyvinylidene difluoride (PVDF) membranes (Millipore Corporation, Bedford, MA). 
Membranes were blocked with 5% fat-free milk and then incubated overnight at 4°C with 
primary antibody in 5% BSA dissolved in Tris-buffered saline (TBS). After being washed 
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with 1XTBS containing 0.05% Tween 20 (TTBS), membranes were incubated with 
secondary antibody at room temperature for 2 h. After TTBS washing, membranes were 
treated with an enhanced chemiluminescence reagent mixture (Thermal Fisher Scientific, 
Rockford, IL) for 5 min and then imaged and analyzed using the Biospectrum imaging 
system (UVP, Upland, CA)
Immunoprecipitation
Cells were washed with cold phosphate-buffered saline (PBS) and collected in 1 ml lysis 
buffer containing 50 mM HEPES (pH 7.4), 150 mM NaCl, 1% Triton X-100, 0.5% NP40, 
50 mM β-glycerophosphate, 1 mM sodium orthovanadate, 10 mM sodium pyrophosphate, 1 
mM EGTA, 1 mM PMSF, 10% glycerol, 100 mM sodium fluoride, 10 μM DETAPAC, 10 
ng/ml leupeptin, and 10 ng/ml aprotinin. 500 μg of whole cell lysate was used for 
immunoprecipitation with ANTI-FLAG M2 Affinity Gel (Sigma-Aldrich) overnight at 4°C. 
The complexes were washed three times with TBS, re-suspended in 100 μl of TBS 
containing 3 μg of 3XFLAG peptide, and incubated at 4°C for 30 min with shaking. After 
centrifuge, the supernatant was collected and used for Western Blots.
Construction of FLAG-Tagged Src plasmids, site-directed mutagenesis, and transfection
pcDNA3 c-Src (47) (Addgene plasmid 42202) was digested with Hind III and Xba I to get 
1.6kb cDNA of human c-Src. The 1.6kb c-Src cDNA was then inserted into p3XFLAG-
CMV-8 Expression vector (Sigma). The plasmid was selected with ampicillin and confirmed 
with DNA sequencing.
Site directed mutagenesis was then performed as described before (48) using a kit (GeneArt 
Site Directed Mutagenesis System, Invitrogen). The primer sequences were as following 
(only forward primer was shown): Src248C/A, 
CCTCACCACCGTGTTCCCCACGTCCAAG; Src277C/A, 
GCTGGGCCAGGGCTTCTTTGGCGAGGTG; Src490C/A, 
CTGCCCGCCGGAGTTTCCCGAGTCCCTG; Src501C/A, 
CCTCATGTGCCAGTTCTGGCGGAAGGAG. The mutations were confirmed with DNA 
sequencing.
Cells were transfected with plasmids with Lipofectamine 2000 when 90% confluence. 
Briefly DNA and Lipofectamine were mixed at 1:3.5 ratio and incubated at RT for 15 min 
before being added to cells. The medium was replaced the next day and 48 h after 
transfection, cells were treated and collected for experiments.
H2O2 measurement
H2O2 was measured in the extracellular media using Amplex Red reagent (10-acetyl-3,7-
dihydroxyphenoxazine). Before treated with TGF-β cell medium was replaced with Krebs–
Ringer phosphate glucose (KRPG) (145 mM NaCl, 5.7 mM sodium phosphate, 4.86 mM 
KCl, 0.54 mM CaCl2, 1.22 mM MgSO4, 5.5 mM glucose, pH 7.35). 120 μl of KRPG was 
collected at different time points after adding of TGF-β. To measure H2O2, 50 μl of sample 
was mixed with same volume of reaction buffer containing Amplex red and horseradish 
peroxidase. The fluorescence signal was detected kinetically with excitation wavelength at 
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529 nm and emission wavelength at 590 nm. The H2O2 concentration was then calculated 
based on standard curve.
Statistical analysis
Data were expressed as mean ± standard error. Wilcoxon rank-Sign test was used for 
statistical analysis of Western densitometry data and t-test was used for analysis of H2O2 
data. Statistical significance was accepted when p < 0.05.
Results
TGF-β activated Src in redox-dependent manner
In the canonical pathway, Src activation depends on dephosphorylation of pTyr530 and 
subsequent phosphorylation at Tyr419. To determine whether Src activation by TGF-β 
follows this mechanism, we first examined the phosphorylation status of Src at Tyr419 and 
Tyr530 at different times after TGF-β exposure. As shown in Figure 1, after addition of 
TGF-β (5 ng/ml), phosphorylation of Src at Tyr419 (pTyr419Src) began to increase at 15 
min and reached its highest level at 30 min. Src activation was sustained until it declined to 
control level after 2 hours of TGF-β exposure. The phosphorylation of Src at Tyr530 
(pTyr530Src) followed a similar pattern; it increased at 15 min, reached its highest level at 
about 30 min, and decreased to control level after 2 hour.
Effect of vanadate on Src activation by TGF-β
This increase in both pTyr419Src and pTyr530Src phosphorylation upon TGF-β stimulation 
demonstrated that dephosphorylation of pTyr530 was not essential for TGF-β-mediated Src 
activation. To further examine this deviation from the canonical pathway, cells were 
pretreated with sodium orthovanadate (vanadate) for 30 min before being exposed to TGF-β. 
Vanadate is a general PTP inhibitor and would be expected to block the enzymatic 
dephosphorylation of Src at Tyr530. Interestingly, vanadate increased both basal and TGF-
β-mediated pTyr530 Src (Figure 2). This suggests that both the tyrosine kinase that catalyzes 
phosphorylation of Tyr530 and the PTP that dephosphorylates Tyr530 are endogenously 
active.
The effect of vanadate on the TGFβ-stimulated phosphorylation of Tyr419Src had a more 
complex dose-dependency. At 0.5 mM, vanadate appeared to inhibit both endogenous Src 
activation and Src activation by TGFβ. At 2 mM vanadate alone activated Src and appeared 
additive with TGFβ in activating Src. At 10 mM vanadate alone increased the level of 
pTyr419Src further and abrogated further stimulation of Src by TGF-β. As Src activation by 
vanadate was additive with TGF-β, pTyr530 dephosphorylation was clearly not required for 
Src activation by TGF-β. The results are possibly due to differential sensitivity to vanadate 
inhibition of PTPs involved in the dephosphorylation of pTyr530 and pTyr419. It appears 
that Tyr530 dephosphorylation is more sensitive to vanadate, resulting in greater pTyr530 at 
lower vanadate concentrations, and leading to more Src in the inhibitory form of pTyr530 
and less pTyr419. At higher vanadate concentrations, both the dephosphorylation of 
pTyr530 and pTyr419 were inhibited, and this resulted in increased pTyr530 and pTyr419.
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Induction of extracellular H2O2 by TGF-β
Previous studies have shown that a redox mechanism is implicated in many 
pathophysiological functions of TGF-β (43,46,49). As Src is a critical mediator of TGF-β 
signaling and its activity is regulated by oxidants. Thus, we hypothesized that Src activation 
by TGF-β could be redox-dependent. To test this, we first determined the production of 
H2O2 by TGF-β using Amplex Red. Upon TGF-β exposure (5 ng/ml), extracellular H2O2 
was significantly increased at as early as 1 min, reached its highest level at 10 min, and was 
back to basal level in 20 min (Figure 3). Catalase (30 U/ml), which catalyzes the dismutation 
of H2O2 to O2 and H2O, completely removed the basal and TGF-β-produced H2O2 in the 
extracellular environment. H2O2 was produced continuously by H358 cells (Figure 3). 
Media incubated without cells did not produce any H2O2.
Redox dependent Src activation by TGF-β
To further study the redox-dependence of Src activation by TGF-β, we next examined the 
effect of antioxidants. GSH-ester, a precursor of intracellular GSH, or catalase, which 
removed extracellular H2O2 as shown above, blocked Src activation (pTyr419Src) by TGF-β 
(Figure 4), indicating that TGF-β-mediated Src activation is accomplished through a redox 
dependent mechanism. Nonetheless, pretreatment with GSH-ester or catalase increased basal 
Src activation as shown by a significant elevation of basal pTyr419Src (Figure 4). This 
occurred concurrently with a decrease in pTyr530Src, suggesting that the basal level of Src 
activation was through redox dependent dephosphorylation of pTyr530. One possible 
explanation for this phenomenon could be the relief by GSH-ester or catalase of the 
inhibition of a PTP, as such enzymes are well known targets for inhibition by H2O2 (26,27).
Involvement of NOX in TGF-β-mediated H2O2 production and Src activation
To determine the source of H2O2, cells were pretreated with apocynin, an inhibitor of 
NADPH oxidases (NOX), before being treated with TGF-β. Pretreatment with 300 μM 
apocynin for 30 min abrogated the increase of H2O2 caused by TGF-β, suggesting that TGF-
β produced H2O2 through activating NOX (Figure 5).
Mutation of cysteine residues decreased Src activation by TGF-β
Cysteine residues in Src are the most likely targets of oxidative modification resulting in Src 
regulation. To identify the cysteine residue(s) in human Src involved in Src activation by 
TGF-β, cysteine residues at 248, 277, 490, or 501 were replaced individually with alanine, 
using site-directed mutation. These cysteine residues were selected because of their 
conservation among Src kinase family members across species (39), or their reported 
sensitivity to redox modification (35,40,50). As shown in Figure 6, the phosphorylation of 
Src at Tyr419 and Tyr530 were affected in different ways by the cysteine/alanine mutation. 
The 248C/A had no effect on the basal level of pTyr419 or pTyr530 of Src. The 277C/A 
mutation did not affect the basal pTyr530Src, but decreased the basal level of pTyr419 Src 
by 50%. The 490C/A mutation decreased the basal level of pTyr530 by 67% and that of 
pTyr419 by 50%, while the 501C/A mutation decreased the basal level of pTyr530 and 
pTyr419 both by about 80%. TGF-β-mediated Src activation was abrogated by C/A 
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mutation at residues 248, 277, or 501, while it was decreased significantly in 490C/A Src 
(52% vs. 120% induction in 490C/A and wild type FLAG-Src respectively).
Discussion
Src activation is responsible for many TGF-β-mediated effects (43-45). The mechanism 
underlying Src activation by TGF-β however, has been unclear. This study demonstrates that 
Src activation by TGF-β is largely through a redox-dependent pathway. In addition, we 
verified that some cysteine residues in Src are critical for Src regulation and mutation of 
cysteine at 277, 490 and 501 to alanine decreases the basal Src activity while mutation of 
cysteine residues at 248, 277, and 501 abrogates TGF-β-mediated Src activation.
In the canonical pathway, Src activation is initiated by dephosphorylation of pTyr530 
followed by a conformational change and subsequent dissociation of intracellular 
interactions and autophosphorylation of Src at Tyr419 (Figure 7B). Our data (Figure 1) 
suggest that a non-canonical mechanism, which does not require the dephosphorylation of 
pTyr530, was involved in TGF-β-mediated Src activation. Inhibition of PTPs (by vanadate 
at 0.5 and 2 mM concentration), which are responsible for the dephosphorylation of 
pTyr530, increased pTyr530 Src, but only inhibited TGF-β-mediated Src activation by~40%. 
In other words, ~60% of Src activation was independent of the dephosphorylation of 
pTyr530. This evidence further supports that both canonical and non-canonical pathways are 
involved in TGF-β-mediated Src activation.
The finding that antioxidants (GSH-ester and catalase) inhibited TGF-β-mediated Src 
activation indicated that Src activation by TGF-β operated, at least partially, through a 
redox-dependent mechanism. The results demonstrated a more complex relationship 
between oxidative Src activation and phosphorylation/dephosphorylation of Src tyrosines. 
Somewhat surprisingly, antioxidants alone decrease the phosphorylation of Src at Tyr530 
while increasing pTyr419. Indeed, this suggests that in H358 cells, there is the potential for 
endogenous activation of Src through the canonical pathway that is inhibited by the 
endogenous H2O2. Removing H2O2 then reveals this endogenous Src activation. Most 
likely, the PTPs that dephosphorylate pTyr530 are inhibited by the endogenous H2O2 so that 
preventing its inactivation allows dephosphorylation of pTyr530 and subsequent 
autophosphorylation of Tyr419; i.e., the canonical pathway. In contrast, Src activation by 
TGF-β was, at least partially, independent of the dephosphorylation of pTyr530. Consistent 
with our finding, Akhand also found that nitric oxide-mediated Src activation was 
independent of the phosphorylation status of Tyr530 (51,52). This was further supported by 
a study from Pu et al. that Hg2+ activated Src in a redox dependent way with the mutation of 
Tyr530 or inhibition of its phosphorylation (51,52). The PTPs involved in the 
dephosphorylation of pTyr530, such as PTP1B (26,27) and SHP-1 (53) are redox sensitive. 
At resting condition, under which H2O2 is constantly produced, a small portion of the PTPs 
are inhibited. The addition of antioxidants would remove this basal H2O2 and thus reduce 
the inhibition on PTPs, resulting in increased dephosphorylation of pTyr530 and a 
subsequent increase in Src activity (the canonical pathway of Src activation).
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Except for PTPs, kinases that phosphorylate Tyr530, including CSK and CHK, can also be 
regulated through redox-dependent mechanisms. Mills et al. reported that CSK activity 
could be regulated through the oxidation state of the disulfide bond in the SH2 domain, 
implying that CSK activity can be affected by redox changes in cells (54). H2O2 production 
may facilitate disulfide bond formation and increase CSK activity, leading to increased 
pTyr530. Furthermore, CSK activity can also be negatively regulated by Src through its 
phosphorylation of the CSK binding protein (CBP), which recruits CSK to the membrane to 
which Src translocates (55). Therefore the phosphorylation status of Tyr530 is regulated by 
a complex network with the net activity determined by the overall effect of these pathways. 
In contrast to current findings, Parasassi reported that supplementation with antioxidants 
such as N-acetylcysteine and dithiothreitol could decrease Src activity by up to 30% in a 
manner independent of the phosphorylation status of Src530 (56). This inconsistency may be 
related to differences in kinases and PTPs involved in the regulation of the phosphorylation 
of either Tyr530 or Tyr419 in the cell types used. Nonetheless, our data suggest that the 
basal Src activity is regulated through redox-dependent dephosphorylation of pTyr530, 
while the TGF-β-mediated Src activation operates mainly through a redox-dependent 
mechanism.
Previous studies have found that TGF-β generates H2O2 through several sources including 
mitochondria (57), NOX1, NOX2 (58), and NOX4 (59). Here, we measured H2O2 in the 
extracellular medium where H2O2 is potentially produced by a membrane NADPH oxidase 
or through the plasma membrane following cytosolic production. The appearance of induced 
extracellular H2O2 in the current study was observed significantly earlier than in previous 
reports of TGF-β-induced intracellular production of H2O2, which occurred 30 min after 
TGF-β exposure and was purportedly due to mitochondria (57) or after 8 h by the 
intracellular NOX4 (59). Here, TGF-β appears to generate H2O2 through a NOX, as the 
NOX inhibitor apocynin blocked elevation of H2O2 and Src activation caused by TGF-β 
(Figure 5). The inhibitory effect of apocynin on NOX depends upon the formation of 
diapocynin, the dimer form, through a process that is cell-type dependent (60). As it is 
unclear whether diapocynin is formed in H358 cells, we cannot be certain of the mechanism 
of the inhibition of apocynin of TGF-β-induced H2O2 production. While H2O2 from NOX4, 
the only NOX located in the cytosol, may affect Src activity later and modulate later events, 
the early production of H2O2 and activation of Src observed here implies involvement of a 
plasma membrane associated NOX rather than NOX4. The evidence supporting this 
assertion is that the inhibition of TGF-β-induced Src activation by extracellular catalase 
would not affect intracellular production of H2O2 because the large extracellular/
intracellular volume would dilute H2O2 coming from an intracellular source even in the 
absence of catalase. Instead, the likely source is a membrane oxidase that increases H2O2 
production extracellularly, either directly or through superoxide production and subsequent 
dismutation to H2O2 and O2.
A possible source of TGF-β produced extracellular H2O2 is NOX1 or NOX2. Rac and 
p47 phox, components of active NOX1 and 2 complex, are potential downstream target of 
TGF-β signaling (58,61). Another potential source of H2O2 is DUOX1, a predominant 
membrane NADPH oxidase in bronchial epithelial cells (62). DUOX1 can be activated 
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through association with p47phox as a result of lipid raft clustering caused by stimulators 
including TNFα (63). Indeed, TGF-β was found to cause lipid raft location of TGF-β 
receptors and regulate signal transduction (64-66). Which member of the NOX family is 
involved has not been determined, but is beyond the scope of the present study.
The redox dependence of TGF-β-mediated Src activation is further supported by the finding 
that activation was abrogated by mutation of cysteine residues in Src. Mutation of Cys248, 
Cys277, or Cys501 to alanine completely inhibited, while that of Cys490 partially inhibited 
TGF-β-mediated Src activation; these findings suggest that cysteines 248, 277. 501, and 490 
might be the targets of oxidative modification by H2O2 produced by TGF-β. Our results are 
consistent with those of Giannoni, et al., who found that Cys245 and Cys498 in v-Src (equal 
to Cys248 and Cys501 respectively in human Src) were critical for Src activation in 
response to ECM (35). Mutation of 490C/A and 501C/A decreased the basal level of 
pTyr419 and pTyr530 significantly, indicating that mutation of these two cysteines to 
alanines might cause conformational change of Src that result in inaccessibility of these 
tyrosine sites to kinases. Senga, et al. also reported that mutation of Cys498 of v-Src could 
suppress Src transforming activity (39). However, it remains to be further clarified how 
these C/A mutations affect Src regulation.
Among the 9 cysteine residues in human Src kinase, Cys 188, 241, and 248 are in the SH2 
domain; Cys 277 and 403 are in the linker region; and Cys486, 490, 499 and 501 are in the 
kinase domain (Figure 7A). The current study and others (35), support the concept that 
Cys248, 277, 490, and 501 play critical roles in the regulation of Src activity. Indeed, 
mutation of cysteine residues in the C-terminus (such as Cys490 and 501) makes Src 
insensitive to redox regulation (29). On the other hand, there are also reports that some 
cysteine residues in Src might be involved in the suppression of Src activity. For instance, 
Cys277 was found to be responsible for oxidant-mediated Src homodimerization and 
inactivation in an in vitro assay (40), and mutation of Cys403 and Cys486 increased Src 
activity (50). Our data support that cysteine residue 248, 277, 490 and 501 of human Src are 
essential for Src activation by TGF-β and are potential targets of oxidative modification. 
Direct modification of cysteine residues in Src has been observed during activation by 
oxidative stimuli such as NO, herbimycin, and other agents (31,51,67). Interestingly Byeon, 
et al. demonstrated that a hydroquinone could bind to cysteine residues and cause Src 
activation (50). This evidence allows for the possibility that some cysteine residues in Src 
might be direct targets of oxidative modification. It still remains largely unknown, however, 
how cysteine modification actually causes Src activation. Some studies suggest there are 
intramolecular disulfide bonds that inhibit Src activity, and that cysteine modification could 
disrupt these disulfide bonds and activate Src (50). Other studies suggest that disulfide 
formation activates Src (14). Our current studies show that cysteine mutation to alanine, 
which prevents formation of disulfide bonds, is more consistent with the latter study.
Conclusion
In summary our data demonstrate three aspects of Src activation by TGF-β in H358 cells. 
H2O2 generation inhibits Src activation, apparently through inhibition of the PTPs that 
dephosphorylate pTyr530. In surprising contrast, TGF-β causes Src activation primarily 
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through a redox-dependent, non-canonical pathway that is independent of the 
dephosphorylation of pTyr530. Finally, mutation of conserved cysteines inhibits TGF-β 
induced Src activation possibly by preventing disulfide formation.
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Highlights
1. TGF-β activates Src in H358 cells largely through a non-canonical redox 
mechanism.
2. TGF-β induces a transient increase in extracellular H2O2 with a peak at 10 min.
3. Cysteine mutations in Src abrogate Src activation by TGF-β.
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Figure 1. 
TGF-β increased Src phosphorylation at both Tyr419 and Tyr530. Cells were exposed to 5 
ng/ml TGF-β for the indicated times and pTyr419 and pTyr530 Src were determined by 
Western Blotting. *, P<0.05, **, P<0.01, compared with control, N=3.
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Figure 2. 
Vanadate reveals non-canonical basal and TGF-β-stimulated Src activation. Cells were 
pretreated with different concentrations of vanadate for 1h before being exposed to TGF-β, 
the cells were then collected and Src phosphorylation at Tyr419 and Tyr530 was determined 
by Western Blotting. *, P<0.05, **, p<0.01, compared with vehicle control; #, p<0.05, ##, 
P<0.01, compared with control of no TGF-β and no vanadate exposure; $, P<0.05 compared 
with TGF-β treatment, N=3.
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Figure 3. 
TGF-β induced increase in extracellular H2O2. H358 cells were exposed to 5 ng/ml TGF-β 
for the times indicated and the extracellular H2O2 level was measured with Amplex Red 
reagent. *, P<0.01 compared with control, N=3.
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Figure 4. 
Effect of antioxidants on TGF-β-mediated Src activation. Cells were exposed to 5 ng/ml 
TGF-β for the indicated times and pTyr419 and pTyr530 Src were determined by Western 
Blotting. *, P<0.05, **, P<0.01 compared with control; #, P<0.05, ##, P<0.01, compared 
with control of no TGF-β, N=3.
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Figure 5. 
TGF-β generated H2O2 through NOX. Apocynin abrogated TGF-β-caused increase of 
extracellular H2O2 level. H358 cells were pretreated with/without 300 μM apocynin for 30 
min and then treated with 5 ng/ml TGF-β for 10 min. H2O2 was measured using Amplex 
Red method. **, P<0.01 compared with control, N=3.
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Figure 6. 
Mutation of cysteine residues in Src decreased Src activation by TGF-β . H358 cells were 
transfected with FLAG-tagged Src plasmids with/without cysteine/alanine mutations for 24 
h and then exposed to 5 ng/ml TGF-β for 1h. FLAG-Src was immunoprecipitated with Anti-
FLAG agarose beads and then the phosphorylation of Src was determined by Western 
blotting. *, P<0.05, **, P<0.01 compared with control, #, P<0.01, compared with control of 
no TGF-β, N=3.
Zhang et al. Page 20
Arch Biochem Biophys. Author manuscript; available in PMC 2016 February 15.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Figure 7. 
Redox regulation of Src by TGF-β. (A) Location of cysteine residues in Src protein; (B) 
possible targets of redox regulation in Src activation pathway by TGF-β.
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